Four Risks Consumers Should Know Before Using DNA Test Results to Buy Life Insurance

1. Coverage Denial Due to Genetic Conditions

Life insurers can refuse coverage or impose exclusions if a DNA test reveals a hereditary condition that increases mortality risk. Even if you have no symptoms, the presence of a gene variant linked to diseases like Huntington's or certain cancers can trigger a denial, especially under non‑participating policies.

2. Premium Hikes or Higher Reserves

Insurers may raise premiums or require higher reserves when genetic markers suggest a higher probability of early death. This adjustment can make a policy unaffordable or shift the risk profile, turning a standard plan into a high‑cost, high‑risk contract.

3. Privacy and Data Misuse

DNA data is highly sensitive. If a company sells or shares genetic information with third parties, insurers can access that data, potentially influencing underwriting beyond the test's intended scope. Consumers must verify that the testing firm has strict data‑sharing policies and that insurers are contractually barred from accessing raw genetic data.

4. Inaccurate or Misinterpreted Results

Genetic tests are probabilistic, not deterministic. A variant may have a low penetrance or be misclassified due to limited research. Relying on such results can lead to unjustified exclusions or mispriced premiums, especially if the insurer misinterprets the test's findings.

Mitigating These Risks

Before using DNA data, compare insurers' genetic underwriting policies, seek transparent disclosure, and consider third‑party advocacy groups that monitor genetic discrimination. Also, verify the lab's accreditation (CLIA, CAP) and the test's clinical validity.